ID   NUDT3_HUMAN             Reviewed;         172 AA.
AC   O95989; B2R8N4;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   10-MAY-2017, entry version 155.
DE   RecName: Full=Diphosphoinositol polyphosphate phosphohydrolase 1;
DE            Short=DIPP-1;
DE            EC=3.6.1.52;
DE   AltName: Full=Diadenosine 5',5'''-P1,P6-hexaphosphate hydrolase 1;
DE            EC=3.6.1.-;
DE   AltName: Full=Nucleoside diphosphate-linked moiety X motif 3;
DE            Short=Nudix motif 3;
GN   Name=NUDT3; Synonyms=DIPP, DIPP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, ENZYME ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, TISSUE SPECIFICITY, AND MUTAGENESIS OF
RP   GLU-70.
RC   TISSUE=Uterus;
RX   PubMed=9822604; DOI=10.1093/emboj/17.22.6599;
RA   Safrany S.T., Caffrey J.J., Yang X., Bembenek M.E., Moyer M.B.,
RA   Burkhart W.A., Shears S.B.;
RT   "A novel context for the 'MutT' module, a guardian of cell integrity,
RT   in a diphosphoinositol polyphosphate phosphohydrolase.";
RL   EMBO J. 17:6599-6607(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Amygdala;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   ENZYME ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=10419486; DOI=10.1074/jbc.274.31.21735;
RA   Safrany S.T., Ingram S.W., Cartwright J.L., Falck J.R., McLennan A.G.,
RA   Barnes L.D., Shears S.B.;
RT   "The diadenosine hexaphosphate hydrolases from Schizosaccharomyces
RT   pombe and Saccharomyces cerevisiae are homologues of the human
RT   diphosphoinositol polyphosphate phosphohydrolase. Overlapping
RT   substrate specificities in a MutT-type protein.";
RL   J. Biol. Chem. 274:21735-21740(1999).
RN   [8]
RP   MUTAGENESIS OF GLY-50; GLY-51; GLY-52; GLU-66; GLY-72; GLY-75; GLY-78;
RP   GLY-82; PHE-84 AND HIS-91.
RX   PubMed=10585413; DOI=10.1074/jbc.274.50.35434;
RA   Yang X., Safrany S.T., Shears S.B.;
RT   "Site-directed mutagenesis of diphosphoinositol polyphosphate
RT   phosphohydrolase, a dual specificity NUDT enzyme that attacks
RT   diadenosine polyphosphates and diphosphoinositol polyphosphates.";
RL   J. Biol. Chem. 274:35434-35440(1999).
RN   [9]
RP   ENZYME ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=12370170; DOI=10.1074/jbc.M209795200;
RA   Fisher D.I., Safrany S.T., Strike P., McLennan A.G., Cartwright J.L.;
RT   "Nudix hydrolases that degrade dinucleoside and diphosphoinositol
RT   polyphosphates also have 5-phosphoribosyl 1-pyrophosphate (PRPP)
RT   pyrophosphatase activity that generates the glycolytic activator
RT   ribose 1,5-bisphosphate.";
RL   J. Biol. Chem. 277:47313-47317(2002).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.25 ANGSTROMS) IN COMPLEX WITH MAGNESIUM IONS;
RP   FLUORIDE AND INOSITOL HEXAKISPHOSPHATE, COFACTOR, AND ENZYME
RP   REGULATION.
RX   PubMed=19585659; DOI=10.1002/prot.22489;
RA   Thorsell A.G., Persson C., Graslund S., Hammarstrom M., Busam R.D.,
RA   Hallberg B.M.;
RT   "Crystal structure of human diphosphoinositol phosphatase 1.";
RL   Proteins 77:242-246(2009).
CC   -!- FUNCTION: Cleaves a beta-phosphate from the diphosphate groups in
CC       PP-InsP5 (diphosphoinositol pentakisphosphate) and [PP]2-InsP4
CC       (bisdiphosphoinositol tetrakisphosphate), suggesting that it may
CC       play a role in signal transduction. InsP6 (inositol
CC       hexakisphophate) is not a substrate. Acts as a negative regulator
CC       of the ERK1/2 pathway. Also able to catalyze the hydrolysis of
CC       dinucleoside oligophosphates, with Ap6A and Ap5A being the
CC       preferred substrates. The major reaction products are ADP and p4a
CC       from Ap6A and ADP and ATP from Ap5A. Also able to hydrolyze 5-
CC       phosphoribose 1-diphosphate. {ECO:0000269|PubMed:9822604}.
CC   -!- CATALYTIC ACTIVITY: Diphospho-myo-inositol polyphosphate + H(2)O =
CC       myo-inositol polyphosphate + phosphate.
CC       {ECO:0000269|PubMed:10419486, ECO:0000269|PubMed:12370170,
CC       ECO:0000269|PubMed:9822604}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:19585659};
CC       Note=Binds 3 Mg(2+) ions per subunit.
CC       {ECO:0000269|PubMed:19585659};
CC   -!- ENZYME REGULATION: Inhibited by fluoride and InsP6.
CC       {ECO:0000269|PubMed:19585659}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=5.9 uM for Ap6A {ECO:0000269|PubMed:10419486,
CC         ECO:0000269|PubMed:12370170, ECO:0000269|PubMed:9822604};
CC         KM=7.7 uM for Ap5A {ECO:0000269|PubMed:10419486,
CC         ECO:0000269|PubMed:12370170, ECO:0000269|PubMed:9822604};
CC         KM=38 mM for 5-phosphoribose 1-diphosphate
CC         {ECO:0000269|PubMed:10419486, ECO:0000269|PubMed:12370170,
CC         ECO:0000269|PubMed:9822604};
CC         KM=4.2 nM for PP-InsP5 {ECO:0000269|PubMed:10419486,
CC         ECO:0000269|PubMed:12370170, ECO:0000269|PubMed:9822604};
CC       pH dependence:
CC         Optimum pH is 7-7.5. {ECO:0000269|PubMed:10419486,
CC         ECO:0000269|PubMed:12370170, ECO:0000269|PubMed:9822604};
CC   -!- SUBUNIT: Monomer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Widely expressed. Expressed at higher level in
CC       brain, heart, pancreas and liver. Also expressed in placenta, lung
CC       and kidney. {ECO:0000269|PubMed:9822604}.
CC   -!- SIMILARITY: Belongs to the Nudix hydrolase family. DIPP subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF062529; AAC83224.1; -; mRNA.
DR   EMBL; AF062530; AAC83225.1; -; mRNA.
DR   EMBL; BT019984; AAV38787.1; -; mRNA.
DR   EMBL; BT019985; AAV38788.1; -; mRNA.
DR   EMBL; AK313440; BAG36231.1; -; mRNA.
DR   EMBL; Z98036; CAI19715.1; -; Genomic_DNA.
DR   EMBL; AL355855; CAI19715.1; JOINED; Genomic_DNA.
DR   EMBL; AL355855; CAH72222.1; -; Genomic_DNA.
DR   EMBL; Z98036; CAH72222.1; JOINED; Genomic_DNA.
DR   EMBL; CH471081; EAX03781.1; -; Genomic_DNA.
DR   EMBL; BC007727; AAH07727.1; -; mRNA.
DR   CCDS; CCDS4791.1; -.
DR   RefSeq; NP_006694.1; NM_006703.3.
DR   UniGene; Hs.188882; -.
DR   PDB; 2FVV; X-ray; 1.25 A; A=1-172.
DR   PDB; 2Q9P; X-ray; 1.65 A; A=1-172.
DR   PDBsum; 2FVV; -.
DR   PDBsum; 2Q9P; -.
DR   ProteinModelPortal; O95989; -.
DR   SMR; O95989; -.
DR   BioGrid; 116336; 43.
DR   IntAct; O95989; 41.
DR   MINT; MINT-1412881; -.
DR   STRING; 9606.ENSP00000351650; -.
DR   iPTMnet; O95989; -.
DR   PhosphoSitePlus; O95989; -.
DR   SwissPalm; O95989; -.
DR   BioMuta; NUDT3; -.
DR   EPD; O95989; -.
DR   MaxQB; O95989; -.
DR   PaxDb; O95989; -.
DR   PeptideAtlas; O95989; -.
DR   PRIDE; O95989; -.
DR   DNASU; 11165; -.
DR   Ensembl; ENST00000607016; ENSP00000476119; ENSG00000272325.
DR   GeneID; 11165; -.
DR   KEGG; hsa:11165; -.
DR   UCSC; uc003ojl.4; human.
DR   CTD; 11165; -.
DR   DisGeNET; 11165; -.
DR   GeneCards; NUDT3; -.
DR   HGNC; HGNC:8050; NUDT3.
DR   HPA; HPA047027; -.
DR   HPA; HPA055953; -.
DR   MIM; 609228; gene.
DR   neXtProt; NX_O95989; -.
DR   OpenTargets; ENSG00000272325; -.
DR   PharmGKB; PA31834; -.
DR   eggNOG; ENOG410ISY6; Eukaryota.
DR   eggNOG; ENOG4111I7R; LUCA.
DR   GeneTree; ENSGT00390000012928; -.
DR   HOGENOM; HOG000237336; -.
DR   HOVERGEN; HBG053341; -.
DR   InParanoid; O95989; -.
DR   KO; K07766; -.
DR   OMA; LQESCLT; -.
DR   OrthoDB; EOG091G0TH6; -.
DR   PhylomeDB; O95989; -.
DR   TreeFam; TF106349; -.
DR   BioCyc; MetaCyc:HS03602-MONOMER; -.
DR   BRENDA; 3.6.1.60; 2681.
DR   Reactome; R-HSA-1855167; Synthesis of pyrophosphates in the cytosol.
DR   SABIO-RK; O95989; -.
DR   SIGNOR; O95989; -.
DR   ChiTaRS; NUDT3; human.
DR   EvolutionaryTrace; O95989; -.
DR   GeneWiki; NUDT3; -.
DR   GenomeRNAi; 11165; -.
DR   PRO; PR:O95989; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000272325; -.
DR   CleanEx; HS_NUDT3; -.
DR   Genevisible; O95989; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0034431; F:bis(5'-adenosyl)-hexaphosphatase activity; IBA:GO_Central.
DR   GO; GO:0034432; F:bis(5'-adenosyl)-pentaphosphatase activity; IBA:GO_Central.
DR   GO; GO:0008486; F:diphosphoinositol-polyphosphate diphosphatase activity; IDA:UniProtKB.
DR   GO; GO:0000298; F:endopolyphosphatase activity; IBA:GO_Central.
DR   GO; GO:0052841; F:inositol bisdiphosphate tetrakisphosphate diphosphatase activity; TAS:Reactome.
DR   GO; GO:0052842; F:inositol diphosphate pentakisphosphate diphosphatase activity; TAS:Reactome.
DR   GO; GO:0052840; F:inositol diphosphate tetrakisphosphate diphosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0052846; F:inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0052847; F:inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0052843; F:inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0052848; F:inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0052844; F:inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0052845; F:inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity; IEA:UniProtKB-EC.
DR   GO; GO:0050072; F:m7G(5')pppN diphosphatase activity; IBA:GO_Central.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:1901911; P:adenosine 5'-(hexahydrogen pentaphosphate) catabolic process; IBA:GO_Central.
DR   GO; GO:0007267; P:cell-cell signaling; TAS:ProtInc.
DR   GO; GO:1901909; P:diadenosine hexaphosphate catabolic process; IBA:GO_Central.
DR   GO; GO:1901907; P:diadenosine pentaphosphate catabolic process; IBA:GO_Central.
DR   GO; GO:0015961; P:diadenosine polyphosphate catabolic process; TAS:ProtInc.
DR   GO; GO:0071544; P:diphosphoinositol polyphosphate catabolic process; IDA:UniProtKB.
DR   GO; GO:0043647; P:inositol phosphate metabolic process; TAS:Reactome.
DR   InterPro; IPR020084; NUDIX_hydrolase_CS.
DR   InterPro; IPR000086; NUDIX_hydrolase_dom.
DR   InterPro; IPR015797; NUDIX_hydrolase_dom-like.
DR   Pfam; PF00293; NUDIX; 1.
DR   SUPFAM; SSF55811; SSF55811; 1.
DR   PROSITE; PS51462; NUDIX; 1.
DR   PROSITE; PS00893; NUDIX_BOX; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm; Hydrolase;
KW   Magnesium; Metal-binding; Reference proteome.
FT   CHAIN         1    172       Diphosphoinositol polyphosphate
FT                                phosphohydrolase 1.
FT                                /FTId=PRO_0000057055.
FT   DOMAIN       17    142       Nudix hydrolase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00794}.
FT   REGION       18     20       Substrate binding.
FT   REGION       89     91       Substrate binding.
FT   MOTIF        51     72       Nudix box.
FT   ACT_SITE     69     69       Proton acceptor. {ECO:0000305}.
FT   METAL        50     50       Magnesium 1; via carbonyl oxygen.
FT   METAL        66     66       Magnesium 2.
FT   METAL        66     66       Magnesium 3.
FT   METAL        70     70       Magnesium 1.
FT   BINDING      10     10       Substrate.
FT   BINDING      41     41       Substrate.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MUTAGEN      50     50       G->A,V: Loss of function.
FT                                {ECO:0000269|PubMed:10585413}.
FT   MUTAGEN      51     51       G->A: Loss of function.
FT                                {ECO:0000269|PubMed:10585413}.
FT   MUTAGEN      52     52       G->A,V: Loss of function.
FT                                {ECO:0000269|PubMed:10585413}.
FT   MUTAGEN      66     66       E->Q: Loss of function.
FT                                {ECO:0000269|PubMed:10585413}.
FT   MUTAGEN      70     70       E->Q: Loss of function.
FT                                {ECO:0000269|PubMed:9822604}.
FT   MUTAGEN      72     72       G->A: Loss of function.
FT                                {ECO:0000269|PubMed:10585413}.
FT   MUTAGEN      75     75       G->A: Loss of function.
FT                                {ECO:0000269|PubMed:10585413}.
FT   MUTAGEN      78     78       G->A: No effect.
FT                                {ECO:0000269|PubMed:10585413}.
FT   MUTAGEN      78     78       G->V: Loss of function.
FT                                {ECO:0000269|PubMed:10585413}.
FT   MUTAGEN      82     82       G->A: Loss of function.
FT                                {ECO:0000269|PubMed:10585413}.
FT   MUTAGEN      84     84       F->Y: Induces a strong decrease in Ap6A
FT                                and [PP]-InsP4 hydrolysis, while it only
FT                                weakly affects PP-InsP5 hydrolysis.
FT                                {ECO:0000269|PubMed:10585413}.
FT   MUTAGEN      91     91       H->L: Induces a strong decrease in Ap6A
FT                                and [PP]-InsP4 hydrolysis, while it only
FT                                weakly affects PP-InsP5 hydrolysis.
FT                                {ECO:0000269|PubMed:10585413}.
FT   STRAND       18     28       {ECO:0000244|PDB:2FVV}.
FT   STRAND       33     38       {ECO:0000244|PDB:2FVV}.
FT   STRAND       45     47       {ECO:0000244|PDB:2FVV}.
FT   STRAND       49     52       {ECO:0000244|PDB:2FVV}.
FT   HELIX        59     71       {ECO:0000244|PDB:2FVV}.
FT   STRAND       73     86       {ECO:0000244|PDB:2FVV}.
FT   TURN         87     90       {ECO:0000244|PDB:2FVV}.
FT   STRAND       91    103       {ECO:0000244|PDB:2FVV}.
FT   HELIX       108    113       {ECO:0000244|PDB:2FVV}.
FT   STRAND      117    121       {ECO:0000244|PDB:2FVV}.
FT   HELIX       122    129       {ECO:0000244|PDB:2FVV}.
FT   TURN        130    132       {ECO:0000244|PDB:2FVV}.
FT   HELIX       134    139       {ECO:0000244|PDB:2FVV}.
SQ   SEQUENCE   172 AA;  19471 MW;  DE823FECF5C6438A CRC64;
     MMKLKSNQTR TYDGDGYKKR AACLCFRSES EEEVLLVSSS RHPDRWIVPG GGMEPEEEPS
     VAAVREVCEE AGVKGTLGRL VGIFENQERK HRTYVYVLIV TEVLEDWEDS VNIGRKREWF
     KIEDAIKVLQ YHKPVQASYF ETLRQGYSAN NGTPVVATTY SVSAQSSMSG IR
//
